Not so different after all

Not so different after all
Though poles apart geographically, the Indian pharmaceutical market shares many similarities with its Latin American counterpart. And many Indian companies are already thriving on these shores. Usha Sharma finds out why

Daiichi Sankyo and Ranbaxy launches Evista in Romania
Daiichi Sankyo and Ranbaxy Laboratories (Ranbaxy) announced that Terapia SA (Terapia Ranbaxy), a subsidiary of Ranbaxy in Romania, will market the osteoporosis medication, Evista in Romania

Mission Vivacare set to commission new facility at Indore
Mumbai-based pharmaceutical and nutraceutical company Mission Vivacare has invested Rs 80 crore for setting up a new manufacturing facility at Pithampur, Indore for pharmaceutical and nutraceutical products

Gates Foundation inks Memorandum with Govt. of India
The Bill & Melinda Gates Foundation announced it’s a critical milestone in the operation of its India AIDS Initiative, ‘Avahan’

Novartis India introduces Otrivin nasal spray
Novartis India’s over-the-counter (OTC) Business Unit, part of Novartis’ operations in India launched Otrivin in a nasal spray format

Neuland Laboratories begins commercial production of peptides
Neuland Laboratories, a global provider of Active Pharmaceutical Ingredients (APIs) and other essential drug discovery and development support services announced successfully commencement of manufacturing of peptides blocks by successfully commercialising the production of Fmoc Pseudoproline Dipeptides and other building blocks in India and the US subsidiary

PLSL completes phase I of type II diabetes molecule in Europe
Piramal Life Sciences (PLSL) completed the phase I study of a new, orally active glucose-lowering compound, P1736, in the Netherlands

SRL to conduct the most affordable swine flu test
The Super Religare Laboratories (SRL) lab in Gurgaon India’s largest network of diagnostic labs recently got an approval from the Government of Delhi to carry out sample collection and testing for Swine Flu in Delhi and NCR

Ranbaxy gets market approval for glycopyrrolate tabs
Ranbaxy Laboratories (RLL) has received approval from the US Food and Drug Administration (FDA) to manufacture and market glycopyrrolate tablets USP, 1 mg and 2 mg

Swissmedic, USFDA approvals for Aurobindo
Aurobindo Pharma has received approval from Swissmedic, Government of Switzerland for the license of Cefepime APL for Injection 1g and 2g

‘Counterfeit’ must not be equated with ‘generic’
Pharmaceutical Research and Manufacturers of America (PhRMA) represents 30 of the world’s leading pharmaceutical research and biotechnology companies. In the past, PhRMA has expressed concern on the status of India’s patent laws and has squared off against Indian generic players. In India recently for CII’s Life Science Conclave 2009, Nancy Adams, Deputy Vice President, Asia, PhRMA took a few queries from Viveka Roychowdhury on PhRMA’s stand on related issues

India Pharma Summit 2009
Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals is organising India Pharma Summit 2009, scheduled on 30 November, 2009 at Hotel Grand Hyatt, Mumbai

Global players to gather at analytica Anacon India 2009
analytica Anacon India in Hyderabad will open its gates for the fifth time on September 29. From then until October 1, 2009, decision-makers and users from the sectors for instrumental analysis, laboratory technology, diagnostics and biotechnology will have a chance to gather information on the latest products and innovations

Sristek Consulting, Sciformix announce Pharmacovigilance Conference
Sristek Consulting and Sciformix Corporation, USA are jointly organising a National Level Pharmacovigilance Conference on: “Issues and Strategies to Promote Drug Safety” on 8th and 9th October 2009, at Hotel Taj Banjara, Hyderabad

Fourth Hanseatic India Colloquium on October 30
Through the efforts of its convener Dr Amal Mukhopadhyay, Founder and CEO of ELGA Biotech, Hamburg, Germany, the Hanseatic India Colloquium is poised to enter its fourth year of existence

Event Brief

‘Project Concern’ unveils the ‘family pharmacist’
All India Drugs Control Officers’ Confederation (AIDCOC) launched ‘Project Concern’ with an aim to create awareness among patients about controlling diseases/disorders through pharmacists. Suja Nair reports

Reforming healthcare and more…
CII’s Life Science Conclave 2009 provided the pharmaceutical and biotechnology industries, global regulatory associations and the Indian Government an opportunity to participate, explore and engage in gauging the needs and potential of the industry in India. Aashruti Kak reports

Official brochure, website of 61st IPC unveiled
The official website for online registration and information pertaining to the 61st Indian Pharmaceutical Congress (IPC) was recently launched